Johnson & Johnson’s $16.6bn Deal for Abiomed Deal a Positive
© Reuters. Johnson & Johnson’s (JNJ) $16.6bn Deal for Abiomed (ABMD) Deal a Positive – Stifel By Sam Boughedda Johnson & Johnson (NYSE:) announced Tuesday that it has agreed a $16.6 billion deal to acquire […]
